(Total Views: 121)
Posted On: 11/11/2019 2:55:57 PM
Post# of 89386

$COCP News Article - Cocrystal Pharma Presents Positive Data from U.S. Phase 2a Study of CC-31244 Demonstrating Ability to Identify Patients More Likely to Respond to Ultrashort Treatment of HCV https://marketwirenews.com/news-releases/cocr...41066.html


My Twitter: WhyteStocks